These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
783 related items for PubMed ID: 18316986
1. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker-Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW. Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986 [Abstract] [Full Text] [Related]
2. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, Butler JC, Schuchat A. J Infect Dis; 2004 Dec 01; 190(11):2031-8. PubMed ID: 15529269 [Abstract] [Full Text] [Related]
3. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW. J Infect Dis; 2006 Jun 01; 193(11):1487-94. PubMed ID: 16652275 [Abstract] [Full Text] [Related]
4. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Pediatr Infect Dis J; 2006 Nov 01; 25(11):1001-7. PubMed ID: 17072121 [Abstract] [Full Text] [Related]
5. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Grivea IN, Panagiotou M, Tsantouli AG, Syrogiannopoulos GA. Pediatr Infect Dis J; 2008 Jun 01; 27(6):519-25. PubMed ID: 18469733 [Abstract] [Full Text] [Related]
6. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R. Clin Microbiol Infect; 2009 Apr 01; 15 Suppl 3():16-20. PubMed ID: 19366365 [Abstract] [Full Text] [Related]
7. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Farrell DJ, Klugman KP, Pichichero M. Pediatr Infect Dis J; 2007 Feb 01; 26(2):123-8. PubMed ID: 17259873 [Abstract] [Full Text] [Related]
8. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL. Clin Infect Dis; 2008 Oct 15; 47(8):989-96. PubMed ID: 18781875 [Abstract] [Full Text] [Related]
9. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Kellner JD, Scheifele D, Vanderkooi OG, Macdonald J, Church DL, Tyrrell GJ. Pediatr Infect Dis J; 2008 Jun 15; 27(6):526-32. PubMed ID: 18458650 [Abstract] [Full Text] [Related]
10. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH. Pediatr Infect Dis J; 2007 Jun 15; 26(6):461-7. PubMed ID: 17529859 [Abstract] [Full Text] [Related]
11. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2007 Oct 19; 56(41):1077-80. PubMed ID: 17947966 [Abstract] [Full Text] [Related]
12. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Sá-Leão R, Nunes S, Brito-Avô A, Frazão N, Simões AS, Crisóstomo MI, Paulo AC, Saldanha J, Santos-Sanches I, de Lencastre H. Clin Microbiol Infect; 2009 Nov 19; 15(11):1002-7. PubMed ID: 19392883 [Abstract] [Full Text] [Related]
13. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Pediatr Infect Dis J; 2009 Apr 19; 28(4):277-82. PubMed ID: 19258924 [Abstract] [Full Text] [Related]
14. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Clin Infect Dis; 2008 Dec 01; 47(11):1388-95. PubMed ID: 18959493 [Abstract] [Full Text] [Related]
16. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia. Parra EL, De La Hoz F, Díaz PL, Sanabria O, Realpe ME, Moreno J. Vaccine; 2013 Aug 20; 31(37):4033-8. PubMed ID: 23680440 [Abstract] [Full Text] [Related]
17. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS. Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392 [Abstract] [Full Text] [Related]
18. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens. Clin Microbiol Infect; 2008 Sep 20; 14(9):835-43. PubMed ID: 18844684 [Abstract] [Full Text] [Related]
19. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT. Pediatr Infect Dis J; 2009 Nov 20; 28(11):990-5. PubMed ID: 19536041 [Abstract] [Full Text] [Related]
20. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER. Clin Infect Dis; 2005 Jun 15; 40(12):1738-44. PubMed ID: 15909260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]